Follow
T Cell
T cell or T lymphocyte is a type of blood cell distinguished by its T cell receptor on the cell surface and plays a key role in the immune response.
OCT 16, 2025 | 3:00 PM
![[Webinar] In Vitro Assays for T Cell Engagers: From Bench to Data-Driven Decisions](https://d3bkbkx82g74b8.cloudfront.net/eyJidWNrZXQiOiJsYWJyb290cy1pbWFnZXMiLCJrZXkiOiJ3ZWJpbmFyX3Byb2ZpbGVfaW1hZ2VfMTFhMWQxODY3ZDIxY2Y0ZDk2NWFlNzdhNTBjZjAyM2EzYmE2ZGI4Nl84MjI3LnBuZyIsImVkaXRzIjp7InRvRm9ybWF0IjoianBnIiwicmVzaXplIjp7IndpZHRoIjo2MDAsImhlaWdodCI6MzAwLCJmaXQiOiJjb3ZlciIsInBvc2l0aW9uIjoiY2VudGVyIiwiYmFja2dyb3VuZCI6IiNmZmYifSwiZmxhdHRlbiI6eyJiYWNrZ3JvdW5kIjoiI2ZmZiJ9fX0=)
Standard bioassays often fall short when evaluating T cell engagers due to their diverse mechanisms of actions (MOAs) and functional complexity. To generate meaningful preclinical data, cont...
OCT 02, 2025 | 8:00 AM
CAR-T Therapy continues to evolve rapidly, mRNA encoding CAR constructs directly to T cells in the bloodstream, potentially enabling CAR T cell production in the body without the need to iso...
OCT 01, 2025 | 7:30 AM
C.E. CREDITS
Non-small cell lung cancer (NSCLC) accounts for more deaths than colon, breast, and prostate cancers combined. Of patients with NSCLC, 20% initially present with stage I or II disease, for w...
On Demand
C.E. CREDITS
Effective functioning of the immune system relies upon systems of checks and balances; too little activity results in overwhelming infection, too much activity results in excessive damage to...
JUN 05, 2025 | 9:00 AM
Harmonizing immunophenotyping assay designs facilitates integrating findings across trials, enabling biomarker identification and validation, revealing cohort-specific features and drug mech...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
MAY 07, 2025 | 8:00 AM
In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLE...
On Demand
C.E. CREDITS
Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer pati...
APR 16, 2025 | 8:00 AM
In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLE...
MAR 26, 2025 | 8:00 AM
In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLE...
MAR 12, 2025 | 8:00 AM
For large-scale enrichment and isolation of immune cells or stem cells for cell therapy applications, common cell purification platforms separate cells based on a single surface antigen. Enr...
JAN 15, 2025 | 9:00 PM
Rapid developments in gene-modified cell therapies, especially CAR T-cell therapies, has increased demand for fast and reliable analytics methods for research, in-process development, and ma...
DEC 04, 2024 | 8:30 AM
Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated exp...
Dec 4, 2024 | 8am PT, 11am ET, 16:00 GMT, 17:00 CET
Immunopeptidomics is a cutting-edge field focused on identifying and characterizing peptides presented by major histocompatibility complex (MHC) Class I and II molecules on cell surfaces. Th...
OCT 16, 2024 | 1:00 PM
C.E. CREDITS
T cell lymphocytes play a central role in the adaptive immune response. They are an essential tool of adoptive cell therapy for the treatment of chronic viral infections and malignant diseas...
On Demand
C.E. CREDITS
The path from research discovery to effective immune cell therapies requires innovative approaches to match the challenges we face. Examining the full richness of biological complexity&mdash...
On Demand
C.E. CREDITS
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
JUN 26, 2024 | 12:00 PM
Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is characterized by malignant T-cell skin infiltration leading to inflammation and skin barrier defects. To effecti...
JUN 18, 2024 | 9:00 AM
Introduction to Magnetic Bead: Understand the history, development, versatility, and impact of Dynabeads magnetic beads: After listening to the podcast, learners will be able to explain the...
JUN 04, 2024 | 8:45 AM
Cancer immunotherapy approaches such as adoptive transfer of chimeric antigen receptor (CAR) T cells or tumor-infiltrating lymphocytes have yielded promising results in hematological maligna...
JUN 04, 2024 | 8:15 AM
The revolution in life science research aims to understand how single cells work, which is crucial for developing new therapies. Traditional methods like FACS and scRNASeq give only a partia...